Literature DB >> 23930906

Gastrointestinal complications of pelvic radiotherapy: medical and surgical management strategies.

Niamh M Hogan1, Michael J Kerin, Myles R Joyce.   

Abstract

Mesh:

Year:  2013        PMID: 23930906     DOI: 10.1067/j.cpsurg.2013.04.004

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN: 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  5 in total

1.  Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study.

Authors:  Aiping Wang; Zongxin Ling; Zhixiang Yang; Pawel R Kiela; Tao Wang; Cheng Wang; Le Cao; Fang Geng; Mingqiang Shen; Xinze Ran; Yongping Su; Tianmin Cheng; Junping Wang
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

2.  Restorative resection of radiation rectovaginal fistula can better relieve anorectal symptoms than colostomy only.

Authors:  Qinghua Zhong; Zixu Yuan; Tenghui Ma; Huaiming Wang; Qiyuan Qin; Lili Chu; Jianping Wang; Lei Wang
Journal:  World J Surg Oncol       Date:  2017-02-02       Impact factor: 2.754

3.  Gut Microbiome and Its Associations With Acute and Chronic Gastrointestinal Toxicities in Cancer Patients With Pelvic Radiation Therapy: A Systematic Review.

Authors:  Jinbing Bai; Zahra A Barandouzi; Claire Rowcliffe; Rebecca Meador; Despina Tsementzi; Deborah Watkins Bruner
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 5.738

4.  Enterovaginal and colovesical fistulas as late complications of pelvic radiotherapy.

Authors:  Masaya Iwamuro; Kou Hasegawa; Yoshihisa Hanayama; Hitomi Kataoka; Takehiro Tanaka; Yoshitaka Kondo; Fumio Otsuka
Journal:  J Gen Fam Med       Date:  2018-06-21

5.  Diverting colostomy is an effective procedure for ulcerative chronic radiation proctitis patients after pelvic malignancy radiation.

Authors:  Xiaoyan Huang; Qinghua Zhong; Huaiming Wang; Jie Zhao; Yingyi Kuang; Qi Guan; Yanjiong He; Qiyuan Qin; Hui Wang; Tenghui Ma
Journal:  BMC Surg       Date:  2020-11-03       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.